Zheng Quan Zhi Xing·2025-07-13 16:09Group 1 - The core viewpoint of the article is that Aibono Medical is implementing a differentiated dividend distribution plan for the year 2024, which excludes shares repurchased by the company from participating in profit distribution [1][4]. - The reason for the differentiated dividend is the company's decision to repurchase shares for employee stock ownership plans, which results in a total share capital of 193,403,175 shares, with 142,800 shares in the repurchase account, accounting for 0.074% of the total [1][2]. - The proposed cash dividend is 3.50 yuan (including tax) per 10 shares for all shareholders, with the total cash dividend distribution amounting to approximately 67.64 million yuan (including tax) [2][3]. Group 2 - The calculation basis for the differentiated dividend indicates that shares in the repurchase account do not have rights to profit distribution, leading to an adjusted total share capital of 193,260,375 shares for the dividend calculation [2][3]. - The ex-dividend reference price is calculated based on the last closing price of 68.85 yuan per share, resulting in an ex-dividend reference price of approximately 68.50 yuan per share [3][4]. - The impact of the differentiated dividend on the ex-dividend reference price is less than 1%, confirming compliance with relevant regulations and ensuring no harm to the interests of the company and its shareholders [4].